News
Stanford breakthrough uses stem cells to create possible cancer vaccine
February 16, 2018 /
MATR Sponsor (view all)
An impressive new study from researchers at Stanford University has found that mice injected with inactivated induced pluripotent stem cells (iPSCs) display significant immune system responses to a variety of cancers. If the study can be replicated in humans this research could pave the way for a groundbreaking personalized cancer treatment that essentially vaccinates patients against many types of tumors.
Rich Haridy
MATR Supporters (view all)
Posted in: Incubators and R&D
Sorry, we couldn't find any posts. Please try a different search.